p 16 INK 4 a and p 15 INK 4 b gene methylations in plasma cells from monoclonal gammopathy of undetermined significance

p15INK4b and p16 INK4a proteins are cell cycle regulators involved in the inhibition of G1 phase progression. High frequency of methylation of both genes has been reported in multiple myeloma (MM), but it remains to be determined how and when these alterations contribute to tumorigenesis. Monoclonal gammopathy of undetermined significance (MGUS) represents an early disease stage in a fraction of MMs. Plasma cells from 33 patients with MGUS and 33 patients with MM were isolated and analyzed for p15INK4b and p16INK4a methylation by methylation-specific polymerase chain reaction. Selective methylation was found in 19% for p16INK4a, 36% for p15INK4b, and 6.5% for both genes in MGUS, and frequencies were similar in MM suggesting that methylation of these genes is an early event, not associated with transition from MGUS to MM. p15INK4b and p16INK4a gene methylation might contribute to immortalization of plasma cells rather than malignant transformation in the natural history of MM. (Blood. 2001;98:244-246)

[1]  A. Roberts,et al.  Role of transforming growth factor-beta signaling in cancer. , 2000, Journal of the National Cancer Institute.

[2]  D. Gonzalez,et al.  De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis , 2000, Leukemia.

[3]  S. Asano,et al.  Expression of p16INK4A and p14ARF in hematological malignancies , 1999, Leukemia.

[4]  R. Bataille,et al.  Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myélome. , 1999, Blood.

[5]  J. Herman,et al.  p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. , 1999, Blood.

[6]  R. Bataille,et al.  14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome. , 1999, Cancer research.

[7]  Santoro,et al.  p16 (INK4a, MTS‐1) gene polymorphism and methylation status in human pituitary tumours , 1999, Clinical endocrinology.

[8]  I. Wong,et al.  Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation. , 1998, British journal of haematology.

[9]  E Gabrielson,et al.  Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Joan,et al.  Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. , 1998, The American journal of pathology.

[11]  H. Koeffler,et al.  Methylation of the p16INK4A gene in multiple myeloma , 1998, British journal of haematology.

[12]  B. Quesnel,et al.  Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. , 1998, Blood.

[13]  P. L. Bergsagel,et al.  Multiple myeloma: increasing evidence for a multistep transformation process. , 1998, Blood.

[14]  J. Decaprio,et al.  Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemia. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  F. Bauters,et al.  Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition. , 1997, Blood.

[16]  K. Post,et al.  Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation , 1997, Molecular carcinogenesis.

[17]  M. Ng,et al.  Frequent hypermethylation of p16 and p15 genes in multiple myeloma. , 1997, Blood.

[18]  Carl W. Miller,et al.  Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma , 1997, British journal of haematology.

[19]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Urashima,et al.  Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells. , 1996, Blood.

[21]  J. Herman,et al.  Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. , 1996, Cancer research.

[22]  W. O'Fallon,et al.  Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R A Kyle,et al.  "Benign" monoclonal gammopathy--after 20 to 35 years of follow-up. , 1993, Mayo Clinic proceedings.